<DOC>
	<DOC>NCT01816893</DOC>
	<brief_summary>The goals of this proposal are to determine the effects of hypoglycemia on the autonomic nervous system and whether administration of a mineralocorticoid receptor antagonist modifies the effects of hypoglycemia on the autonomic nervous system</brief_summary>
	<brief_title>Hypoglycemia and Autonomic Nervous System Function</brief_title>
	<detailed_description />
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<criteria>Healthy volunteers Males and females age 18 to 50 Type I Diabetes Mellitus, OR: Type II Diabetes Mellitus controlled by diet, exercise and oral glycemic control agents (metformin, thiazolidinediones, sulfonylureas) Hemoglobin A1c &gt; 9% (Type 2 Diabetes mellitus) Hemoglobin A1c &lt; 8% or &gt; 10% (Type 1 Diabetes mellitus) Pregnancy Lactation Recurrent hypoglycemic episodes within the past month Subjects who smoke will be required to refrain from smoking for the duration of each study admission Clinically significant coronary artery, cerebrovascular, or peripheral vascular disease, or presence of systemic illness that might affect autonomic function. Such illnesses include diabetes mellitus (controls only) congestive heart failure, hypertension (controls only), renal, pulmonary, hepatic disease, anemia, malignancies, untreated thyroid disease, and alchoholism. Current major depressive illness In both controls and diabetic subjects, any individuals on oral, injected, inhaled or topical corticosteroids within the last year or oral contraceptives within the past 3 months will be excluded. Use of medications other than thyroxine in control subjects Use of medications other than thyroxine, metformin, thiazolidinediones, sulfonylureas, statins, ACE inhibitors, angiotensin receptor blockers (ARBs), and hydrochlorothiazide (HCTZ) in diabetic subjects Blood pressure &gt; 140/90 mmHg. Creatinine &gt; 1.5 mg/dL Serum potassium &gt;5.2 mmol/L Estimated GFR &lt; 50 mL/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Hypoglycemia</keyword>
	<keyword>Autonomic Nervous System</keyword>
</DOC>